Project Grant K01CA292583
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$172K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
This $753,446 Project Grant award from the National Cancer Institute's Cancer Cause and Prevention Research program (CFDA 93.393) aims to adapt and test an intervention to improve cervical cancer screening and follow-up in three diverse, underserved populations: urban inner city Blacks/Haitians in Boston, Hispanic immigrants in Florida, and Hawaiian Natives/Pacific Islanders in Hawaii. The intervention combines education and quality improvement methods using a mechanism called Performance...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $192,489 to the University of Alabama at Birmingham (UAB) from February 1, 2025 to January 31, 2030. The project aims to evaluate the implementation and impact of oncology financial navigation, an evidence-based intervention to help cancer patients manage treatment-related financial hardship. Key activities include: Tracking implementation strategies and their effect on outcomes like...
This federal Project Grant award, totaling $477,869.00, was provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395). The grant aims to develop tailored, multilevel cervical cancer interventions for ethnically diverse Black women, including African American women and Black African immigrant women. The key objectives are to: 1) identify multilevel determinants of routine cervical cancer screening and follow-up adherence among these populations,...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Research Manpower (CFDA 93.398) program, aims to optimize a bundled breast and cervical cancer screening program in Cameroon. The $192,780 award to the University of Alabama at Birmingham (UAB) supports implementation science research to 1) evaluate the reach and effectiveness of the screening program across stationary and mobile clinics, 2) identify implementation outcomes of acceptability, appropriateness,...
This Cooperative Agreement award of $860,545.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports the implementation and evaluation of a Comprehensive Survivorship Care (CSC) intervention across 14 Federally Qualified Health Centers (FQHCs) in South Florida. The project aims to train clinicians, implement the CSC intervention, and evaluate its effectiveness compared to standard survivorship care on patient outcomes such as...
This $172,197 Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) aims to establish and refine processes to facilitate clinical trials in cancer interception (active cancer prevention) at the University of Kansas Cancer Center (KUCC). Key objectives include: Hiring project navigators to support study approvals for principal investigators in non-oncology departments outside KUCC Training research coordinators in cancer prevention trial processes...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $176,534 to Oregon Health & Science University (OHSU) from August 1, 2024 to July 31, 2029. The goals of the research are to: (1) describe cervical cancer screening rates among middle to older age Mexican immigrants at a 23-state network of community health centers (CHCs) from 2012-2023; (2) examine individual, organizational, and structural barriers to cervical cancer...
This $192,433 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program supports a research project to pilot an implementation strategy for increasing the use of mainstream genetic testing (MGT) for colorectal cancer (CRC) patients. The University of Alabama at Birmingham (UAB) will assess barriers to implementing MGT among healthcare providers and institutional stakeholders, as well as patient perceptions, to inform a multi-level...
The National Cancer Institute (NCI) awarded a $168,500 Project Grant under the "Cancer Cause and Prevention Research" (CFDA 93.393) program to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The two-year grant, with an ultimate completion date of July 31, 2025, aims to evaluate physical and mental health symptoms (patient-reported outcomes) throughout the cancer diagnosis trajectory and their associations with cancer outcomes among HIV-positive...
This Project Grant award from the National Institutes of Health under the Trans-NIH Research Support program (CFDA 93.310) provides $1,382,625.00 to Purdue University to address cervical cancer disparities among people experiencing homelessness. The key objectives are to: 1) estimate cervical cancer screening coverage and associated factors among homeless communities in Indiana; 2) identify barriers and facilitators to screening, follow-up, and linkage to care; 3) assess the acceptability and...